Skip to content

IAS: Studies in Uganda show generic fixed-dose combinations safe and effective in children with HIV

Tipranavir moves closer to approval in Europe

IAS: Columbia University is coordinating treatment scale at multiple sites in several sub-Saharan African countries

IAS: TMC114 plus low-dose ritonavir effective and well-tolerated in 3-class-experienced HIV patients

IAS: Routine thyroid testing advised for people taking antiretrovirals

IAS: Use of crystal methamphetamine boosts risk of transmitting drug-resistant HIV

IAS: Kidney disease may be highly prevalent amongst HIV-infected in Africa

IAS: Virological failure rare in patients taking saquinavir / ritonavir

IAS: New tablet formulation of Kaletra is on its way, manufacturer says